Mutual of America Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Mutual of America Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-109,865	Closed	-$2.07M	–	1719
2019 Q3	$2.07M	Sell	109,865 -611	-0.6%	-$6.99K	0.03%	839
2019 Q2	$1.3M	Buy	110,476 +72	+0.1%	+$872	0.02%	1034
2019 Q1	$1.51M	Buy	110,404 +2,004	+2%	+$26K	0.02%	990
2018 Q4	$1.11M	Hold	108,400	–	–	0.02%	1023
2018 Q3	$1.8M	Buy	+108,400	New	+$1.96M	0.03%	940

Mutual of America Capital Management's ALDR Position: Q4 2019 in Review

Mutual of America Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 109,865 shares — an estimated $2.07M sold.

Mutual of America Capital Management first reported a position in ALDR in Q3 2018 and held it in 5 quarters. The position peaked at $2.07M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Mutual of America Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Mutual of America Capital Management sold 109,865 Alder Biopharmaceuticals shares in Q4 2019, an estimated $2.07M.
Mutual of America Capital Management first reported a position in Alder Biopharmaceuticals in Q3 2018 and held it in 5 quarters.
Mutual of America Capital Management's Alder Biopharmaceuticals position peaked at $2.07M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Mutual of America Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.